Science and Enterprise

Category: Joint ventures/collaborations

  • Genomics Consortium Adds Two Members, Gains $49 Million

    The Structural Genomics Consortium (SGC) says it added two new pharmaceutical companies as members and $48.9 million in new funding. The partnership of drug companies and science funding agencies conducts basic drug discovery research, with its findings released to the public domain. SGC added Eli Lilly Canada and Pfizer Inc. to its membership that also…

  • Semiconductor Companies to Invest $4.4B in New York R&D

    Five semiconductor developers said today they will make a joint investment of $4.4 billion over the next five years to develop new computer chip technologies in New York State. The companies include Intel Corporation, IBM, GlobalFoundries, Samsung, and Taiwan Semiconductor Manufacturing Company (TSMC). The investments will be made in current and upgraded facilities in Albany,…

  • Roche, Canadian Not-for-Profit to Partner on New Drugs

    The Centre for Drug Research and Development (CDRD) in Vancouver, Canada and Swiss pharmaceutical maker F. Hoffmann-La Roche Ltd. have agreed to collaborate on development and commercialization of new drug therapies. The exact therapies are yet to be defined, according to the announcement, but will be “for the treatment of diseases with high unmet medical…

  • NYU to Study Response of Rice to Environmental Change

    The National Science Foundation’s Plant Genome Research Program has awarded a $3.6 million grant to New York University to study the response of rice to environmental change. NYU’s Michael Purugganan and Richard Bonneau, who are part of the university’s Center for Genomics and Systems Biology, will head the study, and collaborate with Endang Septiningsih of…

  • Technology Developed for Aerial Vegetation Measurements

    A scientist with the U.S. Department of Agriculture and a technical consultant from industry have developed and patented a technology that converts digital cameras to color infrared cameras for aerial photography. Raymond Hunt, with USDA’s Agricultural Research Service  in Beltsville, Maryland and David Linden, chief scientist at Science Applications International Corporation (SAIC) in McLean, Virginia…

  • U.K. Grant Awarded to Develop Non-Rare Earth Electric Engine

    The Technology Strategy Board in the U.K. has awarded a grant to two companies and a university to develop an engine not dependent on rare earth metals for electric vehicles. The funding worth £518,000 ($US 821,000) to companies Sevcon and Cummins Generator Technologies, and Newcastle University is aimed at building a new type of engine…

  • Mayo Clinic Builds Partnership for Smoke-Free Workplaces

    The Mayo Clinic in Rochester, Minnesota launched today a new program to encourage employers to make their workplaces smoke free. The Global Smoke-Free Worksite Challenge was announced at the annual meeting of the Clinton Global Initiative in New York. The Global Smoke-Free Worksite Challenge is a collaboration among the American Cancer Society, the Global Business…

  • Semiconductor Foundation, NSF Fund Nanoelectronics Research

    Semiconductor Research Corporation (SRC) in Research Triangle Park, North Carolina and National Science Foundation (NSF) are funding $20 million in grants on nanoelectronics research. Some 12 research teams at 24 participating U.S. universities will conduct research over a four-year period on a new switching mechanism using nanoscale electronics as a replacement for current transistors, the…

  • Superbug Therapy Based on University Research in Development

    MGB Biopharma, a biotechnology company in Glascow, U.K., is developing a new antibiotic treatment for resistant infections including MRSA and Clostridium Difficile (C. Diff.) bugs. The company licensed the discoveries from labs at University of Strathclyde, also in Scotland, that they are developing into oral and IV -administered drugs. C. Diff. is a bacterium that…

  • Mayo Clinic, Korean Biotech to Collaborate on ALS Research

    Mayo Clinic’s campus in Jacksonville, Florida and SK Biopharmaceuticals in Seoul, South Korea have agreed to develop new treatments for amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig’s disease. The collaboration will center around the work of Mayo Clinic’s Leonard Petrucelli, who heads the neuroscience research department at the Jacksonville campus. ALS results in…